NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress
Go back to NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress| (NASDAQ: NRXP) | Delayed: 3.95 +0.08 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.87 | 52 Week High | $ | |||
| Open | $3.90 | 52 Week Low | $ | |||
| Day High | $3.96 | P/E | N/A | |||
| Day Low | $3.80 | EPS | $ | |||
| Volume | 620,497 | |||||

